全文获取类型
收费全文 | 69036篇 |
免费 | 6029篇 |
国内免费 | 3303篇 |
专业分类
耳鼻咽喉 | 1092篇 |
儿科学 | 850篇 |
妇产科学 | 787篇 |
基础医学 | 9762篇 |
口腔科学 | 1231篇 |
临床医学 | 7821篇 |
内科学 | 11977篇 |
皮肤病学 | 1344篇 |
神经病学 | 4421篇 |
特种医学 | 3872篇 |
外国民族医学 | 21篇 |
外科学 | 7944篇 |
综合类 | 6338篇 |
现状与发展 | 13篇 |
一般理论 | 18篇 |
预防医学 | 3482篇 |
眼科学 | 1741篇 |
药学 | 6769篇 |
38篇 | |
中国医学 | 2615篇 |
肿瘤学 | 6232篇 |
出版年
2024年 | 150篇 |
2023年 | 828篇 |
2022年 | 2081篇 |
2021年 | 3490篇 |
2020年 | 2410篇 |
2019年 | 2405篇 |
2018年 | 2538篇 |
2017年 | 2174篇 |
2016年 | 2413篇 |
2015年 | 3482篇 |
2014年 | 4022篇 |
2013年 | 3979篇 |
2012年 | 5724篇 |
2011年 | 5918篇 |
2010年 | 3727篇 |
2009年 | 2954篇 |
2008年 | 3834篇 |
2007年 | 3778篇 |
2006年 | 3509篇 |
2005年 | 3255篇 |
2004年 | 2444篇 |
2003年 | 2181篇 |
2002年 | 1859篇 |
2001年 | 1225篇 |
2000年 | 1192篇 |
1999年 | 1205篇 |
1998年 | 680篇 |
1997年 | 666篇 |
1996年 | 521篇 |
1995年 | 455篇 |
1994年 | 411篇 |
1993年 | 247篇 |
1992年 | 399篇 |
1991年 | 318篇 |
1990年 | 292篇 |
1989年 | 257篇 |
1988年 | 234篇 |
1987年 | 200篇 |
1986年 | 177篇 |
1985年 | 127篇 |
1984年 | 86篇 |
1983年 | 86篇 |
1982年 | 42篇 |
1981年 | 45篇 |
1980年 | 29篇 |
1979年 | 40篇 |
1978年 | 26篇 |
1976年 | 35篇 |
1974年 | 27篇 |
1972年 | 27篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
101.
Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans. 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
M Hara M Han 《Proceedings of the National Academy of Sciences of the United States of America》1995,92(8):3333-3337
Attachment of Ras protein to the membrane, which requires farnesylation at its C terminus, is essential for its biological activity. A promising pharmacological approach of antagonizing oncogenic Ras activity is to develop inhibitors of farnesyltransferase. We use Caenorhabditis elegans vulval differentiation, which is controlled by a Ras-mediated signal transduction pathway, as a model system to test previously identified farnesyltransferase inhibitors. We show here that two farnesyltransferase inhibitors, manumycin and gliotoxin, suppress the Multivulva phenotype resulting from an activated let-60 ras mutation, but not the Multivulva phenotype resulting from mutations in the lin-1 gene or the lin-15 gene, which act downstream and upstream of let-60 ras, respectively, in the signaling pathway. These results are consistent with the idea that the suppression of the Multivulva phenotype of let-60 ras by the two inhibitors is specific for Ras protein and that the mutant Ras protein might be more sensitive than wild-type Ras to the farnesyltransferase inhibitors. This work suggests that C. elegans vulval development could be a simple and effective in vivo system for evaluation of farnesyltransferase inhibitors against Ras-activated tumors. 相似文献
102.
103.
目的 对比观察头孢噻肟(CTX)与其他两种抗菌药物治疗方案对30例血液病合并感染患者杀 菌活性(SBA)及临床疗效。方法SBA采用微量稀释法测定,临床疗效根据临床治疗登记表按三 级标准判定。结果与结论 头孢噻肟的临床反应最佳,杀菌作用时间维持较长,但对绿脓假单胞 菌和阴沟肠杆菌杀菌作用较差;呱拉西林(PIP)与阿米卡星(AN)方案的抗菌谱广,但PIP杀菌 作用时间较短,可考虑缩短给药间期,而AN可按一日一次给全日量的方案,以提高疗效减少不 良反应;头孢哌酮(CPZ)可主要用于绿脓假单胞菌感染,也可用于其它细菌的混合感染,但给药 间隔时间以一日三次为宜。 相似文献
104.
Jung Han Kim Sang Jun Lee Young Bok Han Jung Jo Moon Jong Bae Kim 《Archives of pharmacal research》1994,17(2):115-118
This paper describes the isolation of isoguanosine from Croton tiglium L. and its cytotoxic effect against several tumor cell lines in culture and newly reports that isoguanosine has an antitumor activity against implanted S-180 ascitic tumor mice. Isoguanosine is effective at the dose of 24 mg/kg/day x 5, with T/C value of 168%. Isoguanosine inhibits the growth of S-180 and Ehrlich solid tumor in mice at the optimal doses of 96 mg/kg/day x 12 and 48 mg/kg/day x 12, with 1-T/C values of 65% and 60%, respectively. 相似文献
105.
从芫花Daphne genkwa条的乙酸乙酯可溶部分分到3个结果性化合物,借助于波谱分析手段推断出Ⅱ为西瑞香素,Ⅲ为daphnodorin B。 相似文献
106.
山莨菪碱防治甘油所致急性肾功能衰竭的实验研究 总被引:2,自引:0,他引:2
在129只SD大鼠的实验中动态观察了山莨菪碱对甘油所致急性肾功能衰竭时不同时期的Bcr,BUN,pH病理改变及死亡率的影响,结果表明:山莨菪碱能降低ARF第5天大鼠死亡率以及Bcr,BUN水平。改善病理损害,对ARF起到预防及治疗效果,山莨菪碱的预防效果优于治疗效果,预防是ARF防治的关键,但山莨菪碱在治疗过程中要引起“冲刷综合征”导致洗脱性酸中毒,应引起注意。 相似文献
107.
用带血管的胎儿甲状旁腺移植术治疗甲状旁腺机能低下症,共行手术6次(腹腔内移植5次,股三角区移植1次),6次中有3例术后发生4次排斥反应。经1年8月至3.5年随防,疗效显著者2例,有效2例,失败1例。本文讨论了有关甲状旁腺移植的手术方法、注意事项、免疫抑制剂应用等问题。 相似文献
108.
109.
110.
Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy. 总被引:6,自引:0,他引:6
Joo Hyun Kang June-Key Chung Yong Jin Lee Jae Hoon Shin Jae Min Jeong Dong Soo Lee Myung Chul Lee 《Journal of nuclear medicine》2004,45(9):1571-1576
To evaluate the possibility of radionuclide gene therapy and imaging in hepatocellular carcinoma cancer, we investigated the iodine accumulation of a human hepatocellular carcinoma cell line, SK-Hep1, by transfer of human sodium iodide symporter (hNIS) gene. By targeting NIS expression in SK-Hep1, we could also investigate whether these cells concentrate 99mTc-pertechnetate and 188Re-perrhenate as well as 125I in vitro and in vivo. METHODS: The hNIS gene was transfected to human hepatocellular carcinoma SK-Hep1 cell lines using lipofectamine plus reagent. The uptake and efflux of 125I, 99mTc-pertechnetate, and 188Re-perrhenate were measured in the transfected and parental cells. Biodistribution was studied in nude mice bearing SK-Hep1 and SK-Hep1-NIS at 10 and 30 min and at 1, 2, 6, 16, and 23 h after injection of 125I, 99mTc- pertechnetate, or 188Re-perrhenate. In tumor imaging studies, the nude mice were intravenously injected with 188Re-perrhenate and imaged with a gamma-camera equipped with a pinhole collimator at 30 and 60 min after injection. The survival rate (%) was determined by the clonogenic assay after 37 MBq/10 mL (1 mCi/10 mL) 131I and 188Re-perrhenate treatment. RESULTS: SK-Hep1-NIS, stably expressing the NIS gene, accumulated 125I up 150 times higher than that of SK-Hep1. Iodine uptake of SK-Hep1-NIS is completely blocked by perchlorate. NIS gene transfection into SK-Hep1 also resulted in 112- and 87-fold increases of 99mTc-pertechnetate and 188Re-perrhenate uptake, respectively. Iodide efflux from SK-Hep1-NIS was relatively slow, with only 10% released during the initial 5 min, and 60% remained at 25 min. In the biodistribution study using SK-Hep1-NIS-xenographed mice, the tumor uptake of 125I, 188Re-perrhenate, and 99mTc-pertechnetate was 68.0 +/- 15.0, 46.2 +/- 9.1, and 59.6 +/- 16.2 %ID/g (percentage injected dose per gram) at 2 h after injection, respectively. After 188Re-perrhenate injection in SK-Hep1 and SK-Hep1-NIS-xenographed nude mice, whole-body images clearly visualized the SK-Hep1-NIS tumor, whereas the control tumor was not visualized. The survival rate (%) of SK-Hep1-NIS was markedly reduced to 46.3% +/- 10.1% and 28.9% +/- 5.2% after 37 MBq/mL (1 mCi/10 mL) 131I and 188Re-perrhenate treatment compared with the survival rates of the parental cells. These results demonstrated that SK-Hep1-NIS could be selectively killed by the induced 131I and 188Re-perrhenate accumulation through NIS gene expression. CONCLUSION: NIS-based gene therapy using beta-emitting radionuclides has the potential to be used in hepatocellular carcinoma management. 相似文献